Clincosm LogoSign in Get a demo

Breast Cancer

Showing NaN - NaN of 209
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mammaplasty, Breast Cancer, Poland Syndrome Trial in Worldwide (Motiva Flora® Tissue Expander)

Recruiting
  • Mammaplasty
  • +2 more
  • Motiva Flora® Tissue Expander
  • Ghent, Belgium
  • +3 more
Nov 29, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Duarte, California
  • +111 more
Oct 23, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Orange City, Florida
  • +27 more
Jul 19, 2023

Sentinel Lymph Node, Breast Cancer, Locally Advanced Trial in Hospitalet de Llobregat, Barcelona (Target Axillary Dissection)

Recruiting
  • Sentinel Lymph Node
  • +2 more
  • Target Axillary Dissection
  • Hospitalet de Llobregat, Barcelona, Spain
  • +1 more
Mar 11, 2023

Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Brussels, Barcelona, Madrid (JK08)

Recruiting
  • Cancer
  • +6 more
  • Brussels, Belgium
  • +3 more
Jan 30, 2023

Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +23 more
Jan 30, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (LY3484356, Abemaciclib, Everolimus)

Recruiting
  • Breast Cancer
  • +3 more
  • Gilbert, Arizona
  • +76 more
Jan 27, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Paclitaxel, Nab-paclitaxel)

Recruiting
  • Breast Cancer
  • Duarte, California
  • +260 more
Jan 19, 2023

Breast Cancer Trial in Spain (Olaparib)

Terminated
  • Breast Cancer
  • Barcelona, Spain
  • +7 more
Jan 18, 2023

Breast Cancer, Breast Cancer Metastatic Trial in Spain (Niraparib 100 MG, Aromatase Inhibitors)

Terminated
  • Breast Cancer
  • Breast Cancer Metastatic
  • Niraparib 100 MG
  • Aromatase Inhibitors
  • A Coruña, Spain
  • +9 more
Jan 17, 2023

Breast Cancer Trial in Worldwide (Perjeta, Herceptin, Docetaxel)

Active, not recruiting
  • Breast Cancer
  • Bruxelles, Belgium
  • +55 more
Jan 18, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Capecitabine)

Recruiting
  • Breast Cancer
  • Gilbert, Arizona
  • +165 more
Jan 17, 2023

Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,

Recruiting
  • Breast Neoplasms
  • +2 more
  • Trastuzumab Deruxtecan
  • +5 more
  • Springdale, Arkansas
  • +203 more
Jan 13, 2023

Breast Cancer, Solid Tumor Trial in Worldwide (Inavolisib, Fulvestrant, Letrozole)

Recruiting
  • Breast Cancer
  • Solid Tumor
  • Boston, Massachusetts
  • +12 more
Jan 10, 2023

Breast Cancer Trial in Worldwide (Atezolizumab, Trastuzumab Emtansine, Placebo)

Recruiting
  • Breast Cancer
  • Alabaster, Alabama
  • +305 more
Jan 10, 2023

Breast Cancer Trial in Worldwide (Inavolisib, Placebo, Palbociclib)

Recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +228 more
Jan 10, 2023

Breast Cancer Trial in Worldwide (trastuzumab, trastuzumab emtansine)

Active, not recruiting
Has Results
  • Breast Cancer
  • Anchorage, Alaska
  • +275 more
Dec 13, 2022

Breast Cancer Trial in Worldwide (Ipatasertib, Placebo, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Atlanta, Georgia
  • +19 more
Dec 5, 2022

Breast Cancer, Non-small Cell Lung Carcinoma Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Pembrolizumab)

Recruiting
  • Breast Cancer
  • Non-small Cell Lung Carcinoma
  • San Francisco, California
  • +24 more
Nov 30, 2022

Breast Cancer Trial in Worldwide (Dato-DXd, Capecitabine, Gemcitabine)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +172 more
Dec 1, 2022

Breast Cancer Trial (Patritumab deruxtecan, Chemotherapy, Letrozole)

Recruiting
  • Breast Cancer
  • Patritumab deruxtecan
  • +2 more
  • Barcelona, Spain
    Hospital Clinic de Barcelona
Nov 28, 2022

Breast Cancer Trial in Worldwide (Olaparib, Placebo)

Active, not recruiting
Has Results
  • Breast Cancer
  • Anchorage, Alabama
  • +698 more
Nov 25, 2022

Solid Tumor, Breast Cancer, Cancer of Head and Neck Trial in Worldwide (RO6874281, Trastuzumab, Cetuximab)

Completed
  • Solid Tumor
  • +2 more
  • Tucson, Arizona
  • +25 more
Nov 21, 2022

Breast Cancer Trial in Worldwide (Alpelisib, Fulvestrant, Letrozole)

Active, not recruiting
  • Breast Cancer
  • Gilbert, Arizona
  • +93 more
Nov 10, 2022

Breast Cancer, Prostate Cancer, Quality of Life Trial in Worldwide (ASCAPE-based follow-up strategy)

Recruiting
  • Breast Cancer
  • +4 more
  • ASCAPE-based follow-up strategy
  • Athens, Greece
  • +4 more
Oct 28, 2022